Asiyat Z. Khashukoeva

Asiyat Z. Khashukoeva

Auto-generated profile, based on publicly available information

Asiyat Z. Khashukoeva

Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
VSVladimir Sobolev
Vladimir Sobolev
AKAsiat Z. Khashukoeva
Asiat Z. Khashukoeva
OEOlga E. Evina
Olga E. Evina
NGNatalia Geppe
Natalia Geppe
SCSvetlana Chebysheva
Svetlana Chebysheva
AMAlexandre Mezentsev
Alexandre Mezentsev
The transcription factor FOSL1 plays an important role in cell differentiation and tumorigenesis. Primarily, FOSL1 is crucial for the differentiation of several cell lineages, namely adipocytes, chondrocytes, and osteoblasts. In solid tumors, FOSL1 controls the progression of tumor cells through the epithelial–mesenchymal transformation. In this review, we summarize the available data on FOSL1 expression, stabilization, and degradation in the cell. We discuss how FOSL1 is integrated into the intracellular signaling mechanisms and provide a comprehensive analysis of FOSL1 influence on gene expression. We also analyze the pathological changes caused by altered Fosl1 expression in genetically modified mice. In addition, we dedicated a separate section of the review to the role of FOSL1 in human cancer. Primarily, we focus on the FOSL1 expression pattern in solid tumors, FOSL1 importance as a prognostic factor, and FOSL1 perspectives as a molecular target for anticancer therapy.

22 March 2016 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
VZV. V. Zverev
V. V. Zverev
OMO. V. Makarov
O. V. Makarov
AKA. Z. Khashukoeva
A. Z. Khashukoeva
OSOksana Svitich
Oksana Svitich
YDY. E. Dobrokhotova
Y. E. Dobrokhotova
LGL. V. Gankovskaya
L. V. Gankovskaya

9 October 2022 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AKA. Z. Khashukoeva
A. Z. Khashukoeva
TDT. Y. Dmitrashko
T. Y. Dmitrashko
LNL. A. Nosova
L. A. Nosova
EME. A. Markova
E. A. Markova
AOA. V. Overko
A. V. Overko
As a result of the age-related decline in reproductive function, during the perimenopausal and postmenopausal periods female patients experience an estrogen deficiency state. Due to this state, symptoms of estrogen deficiency, which are combined into the concept of “climacteric syndrome”, begin to manifest. Climacteric syndrome is a complex of vegetative-vascular, mental, and metabolic-endocrine disorders that develop in women not only due to decrease in estrogen synthesis, but also the general ageing of the body. Clinical manifestations of the climacteric syndrome have a certain priority of development. With a decrease of the hormonal function of the ovaries, vasomotor disorders step forward. They represent all forms of autonomic regulation disorders, such as hot flashes, arterial pressure and pulse liability, respiratory disorders, hyperhydrosis, chills, and many others. In this article, the greatest emphasis is placed on the issue of vasomotor disorders, in particular hot flashes, in women of the perimenopausal and postmenopausal periods. Attention is paid to the medical and social component of the issue discussed. Given the fact that today the life expectancy of people, including women, is significantly increasing in the developed countries, a large number of females are faced with the issue of menopausal syndrome. The clinical manifestations of menopause not only have an extremely negative impact on the women’s quality of life, but also lay the groundwork for the development of more severe somatic disorders. The article also considers in detail the frequency of hot flashes, and the pathogenetic mechanisms of their development. The “gold standard” for the treatment of patients suffering from vasomotor disorders is particularly detailed. Today, the menopausal hormone therapy is recognized as the most effective therapeutic approach, which, subject to a personalized approach to patients and the absence of contraindications to its prescription, demonstrates high protective capabilities.

29 May 2020 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
KKKhashukoeva A.Z. Khashukoeva
Khashukoeva A.Z. Khashukoeva
IIIlyina I.YU. Ilyina
Ilyina I.YU. Ilyina
KKKerchelaeva S.A. Kerchelaeva
Kerchelaeva S.A. Kerchelaeva

1 January 1996
Verified
Journal Article
Closed access
LAL V Adamian
L V Adamian
ZZZ R Zurabiani
Z R Zurabiani
SKS I Kiselev
S I Kiselev
AKAsiyat Z. Khashukoeva
Asiyat Z. Khashukoeva

21 July 2020 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
KKKhashukoeva A.Z. Khashukoeva
Khashukoeva A.Z. Khashukoeva
DDDobrokhotova Yu.E. Dobrokhotova
Dobrokhotova Yu.E. Dobrokhotova
KKKhlynova S.A. Khlynova
Khlynova S.A. Khlynova
MEMarkova E.A. Markova E
Markova E.A. Markova E
SSSukhova T.N. Sukhova
Sukhova T.N. Sukhova
MMMyasoutova A.I. Myasoutova
Myasoutova A.I. Myasoutova